Volume 28, Issue 3 - Trends in medical writing

My First Medical Writing

Authors: Evguenia Alechine, Mayya Sundukova

Abstract

Download the full article

References

1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10(4):287–333.
2. Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: A systematic review and meta-analysis. JAMA. 2018;320(23):2448–60.
3. Shaikh SS, Nahorski MS, Woods CG. A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site. Mol Pain. 2018;14:1744806918809223.
4. Carvalho OP, Thornton GK, Hertecant J, Houlden H, Nicholas AK, Cox JJ, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet. 2011;48:131–5.
5. Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, Solders G, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004;13(8):799-805.
6. Wood JN. Nerve growth factor and pain. N.Engl J Med. 2010;363(16):1572–3.
7. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol. 1994;36(2):244–6.
8. Cohen SP, Chang D, Hsu E, Hottinger D. Anti-nerve growth factor in pain management: current evidence. J Pain Res. 2016;9:373–83.
9. Hochberg MC. Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies. Osteoarthr Cartil. 2015;23 Suppl 1:S18–21.
10. Nocchi L, Portulano C, Franciosa F, et al. Nerve growth factor-mediated photo - ablation of nociceptors reduces pain behavior in mice. Pain. Epub 2019 Jun 26.
11. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2011;17(12):1685–91.
12. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier: NCT02422979, Study of RM- 1929 and photoimmunotherapy in patients with recurrent head and neck cancer. 2015 [cited 2019 Aug 10]. Available from: https://clinicaltrials.gov/ct2/show/ NCT02422979.
13. Gregory NS, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA. An overview of animal models of pain: Disease models and outcome measures. J Pain. 2013;14:1255–69.
14. Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284.
15. Nocchi L, Roy N, D’Attilia M, Dhandapani R, Maffei M, Traista A, et al. Interleukin- 31-mediated photoablation of pruritogenic epidermal neurons reduces itch-associated behaviours in mice. Nat Biomed Eng. 2019;3,114–25.